Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperlipidemia. When does treatment make a difference?

G R Wise1, T T Schultz

  • 1Division of General Internal Medicine and Geriatric Medicine, Loma Linda University Medical Center, CA 92350, USA. gwise@ccmail.illu.edu

Postgraduate Medicine
|July 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of ColoCARE versus Hemoccult SENSA for fecal occult blood testing in high-risk patients.

The American journal of gastroenterology·1996
Same author

Clinical uses for low-molecular-weight heparins.

The Western journal of medicine·1996
Same author

Colocare self-test versus Hemoccult II Sensa for fecal occult blood testing.

The American journal of gastroenterology·1995
Same author

Evaluation of involuntary weight loss. Where do you start?

Postgraduate medicine·1994
Same author

Cardiovascular risk factors in people older than 65.

The Western journal of medicine·1992
Same author

QA in the resident clinic.

QA review : quality assurance news and views·1990
Same journal

Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures.

Postgraduate medicine·2026
Same journal

Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

Postgraduate medicine·2026
Same journal

The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

Postgraduate medicine·2026
Same journal

Operational and demographic predictors of leaving without being seen in a high-volume tertiary emergency department: a five-year case-control study.

Postgraduate medicine·2026
Same journal

Risk of adverse effects of the concomitant use of statins with calcium channel blockers: a systematic review and meta-analysis.

Postgraduate medicine·2026
Same journal

Association between frailty and major chronic disease-free life expectancy: a large community-based longitudinal study.

Postgraduate medicine·2026
See all related articles

Early screening and management of high cholesterol (hyperlipidemia) are crucial for preventing coronary atherosclerosis. Lifestyle changes and statins are key treatments to lower lipid levels and reduce cardiovascular risk.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Metabolic Disorders

Background:

  • High serum cholesterol is a primary driver of coronary atherosclerosis.
  • Early detection of hyperlipidemia is vital for cardiovascular health.
  • Screening guidelines recommend specific ages for men and women, with earlier screening for those with risk factors.

Purpose of the Study:

  • To outline screening recommendations for hyperlipidemia.
  • To detail diagnostic assessments for abnormal lipid levels.
  • To provide a treatment approach for managing high cholesterol.

Main Methods:

  • Screening for hyperlipidemia based on age and risk factors.
  • Assessing lipid profiles, including high-density lipoprotein and triglyceride levels.

Related Experiment Videos

  • Implementing nonpharmacologic interventions (diet, exercise, weight loss, smoking cessation).
  • Initiating pharmacologic therapy, primarily statins, when lifestyle changes are insufficient.

    • Main Results:

    • Established guidelines for initiating hyperlipidemia screening.
    • Defined diagnostic steps for further assessment of lipid levels.
    • Highlighted the efficacy of lifestyle modifications and statin therapy in managing hyperlipidemia.
    • Recommended adjunctive pharmacologic interventions for specific patient populations.

    Conclusions:

    • Consistent identification and management of hyperlipidemia are essential.
    • Setting target lipid goals and addressing modifiable risk factors improve outcomes.
    • Pharmacologic interventions, particularly statins, play a significant role in achieving lipid-lowering goals.
    • Comprehensive management strategies are necessary to prevent coronary atherosclerosis.